Analysis of Tissue Plasminogen Activator Eligibility by Sex in the Greater Cincinnati/Northern Kentucky Stroke Study
Author(s) -
Tracy E. Madsen,
Jane Khoury,
Kathleen Alwell,
Charles J. Moomaw,
Brett Kissela,
Felipe De Los Rios La Rosa,
Daniel Woo,
Opeolu Adeoye,
Matthew L. Flaherty,
Pooja Khatri,
Simona Ferioli,
Dawn Kleindorfer
Publication year - 2015
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.114.006737
Subject(s) - medicine , stroke (engine) , blood pressure , population , tissue plasminogen activator , demography , gerontology , mechanical engineering , environmental health , sociology , engineering
Sex differences in recombinant tissue-type plasminogen activator (r-tPA) administration are present in some populations. It is unknown whether this is because of eligibility differences or the modifiable exclusion criterion of severe hypertension. Our aim was to investigate sex differences in r-tPA eligibility, in individual exclusion criteria, and in the modifiable exclusion criterion, hypertension.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom